{"id":"https://openalex.org/W4390031850","doi":"https://doi.org/10.1186/s40545-023-00655-9","title":"Changes in prescribing of psychotropic vs some physical health medication in primary care through the COVID-19 pandemic in England: a national-level survey","display_name":"Changes in prescribing of psychotropic vs some physical health medication in primary care through the COVID-19 pandemic in England: a national-level survey","publication_year":2023,"publication_date":"2023-12-21","ids":{"openalex":"https://openalex.org/W4390031850","doi":"https://doi.org/10.1186/s40545-023-00655-9","pmid":"https://pubmed.ncbi.nlm.nih.gov/38124123","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10734137"},"language":"en","primary_location":{"id":"doi:10.1186/s40545-023-00655-9","doi":"https://doi.org/10.1186/s40545-023-00655-9","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s40545-023-00655-9","pdf_url":"https://joppp.biomedcentral.com/counter/pdf/10.1186/s40545-023-00655-9","source":{"id":"https://openalex.org/S2737254583","display_name":"Journal of Pharmaceutical Policy and Practice","issn_l":"2052-3211","issn":["2052-3211"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","norway-1","oarl","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmaceutical Policy and Practice","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://joppp.biomedcentral.com/counter/pdf/10.1186/s40545-023-00655-9","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031879466","display_name":"Unaiza Waheed","orcid":"https://orcid.org/0000-0003-2029-8951","observed_orcids":["https://orcid.org/0000-0003-2029-8951"]},"institutions":[{"id":"https://openalex.org/I2801120809","display_name":"Salford Royal NHS Foundation Trust","ror":"https://ror.org/019j78370","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2801120809","https://openalex.org/I4405259061"]},{"id":"https://openalex.org/I4210111611","display_name":"Salford Royal Hospital","ror":"https://ror.org/027rkpb34","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210111611","https://openalex.org/I4405259061"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Unaiza Waheed","raw_affiliation_strings":["Department of Diabetes and EndocrinologySalford Royal Hospital\rM6 8HD\rSalford\rUK","Department of Diabetes and Endocrinology, Salford Royal Hospital, Salford, M6 8HD, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Diabetes and EndocrinologySalford Royal Hospital\rM6 8HD\rSalford\rUK","institution_ids":["https://openalex.org/I2801120809","https://openalex.org/I4210111611"]},{"raw_affiliation_string":"Department of Diabetes and Endocrinology, Salford Royal Hospital, Salford, M6 8HD, UK","institution_ids":["https://openalex.org/I2801120809","https://openalex.org/I4210111611"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055552232","display_name":"Mike Stedman","orcid":"https://orcid.org/0000-0002-0491-7823","observed_orcids":["https://orcid.org/0000-0002-0491-7823"]},"institutions":[{"id":"https://openalex.org/I2799725268","display_name":"Manchester Academic Health Science Centre","ror":"https://ror.org/04rrkhs81","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799725268"]},{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mike Stedman","raw_affiliation_strings":["The School of Medicine and Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The School of Medicine and Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK","institution_ids":["https://openalex.org/I2799725268","https://openalex.org/I28407311"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035336506","display_name":"Mark Davies","orcid":"https://orcid.org/0000-0002-8011-0300","observed_orcids":["https://orcid.org/0000-0002-8011-0300"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark Davies","raw_affiliation_strings":["Res Consortium, Andover, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Res Consortium, Andover, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043650421","display_name":"Emma Solomon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801120809","display_name":"Salford Royal NHS Foundation Trust","ror":"https://ror.org/019j78370","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2801120809","https://openalex.org/I4405259061"]},{"id":"https://openalex.org/I4210111611","display_name":"Salford Royal Hospital","ror":"https://ror.org/027rkpb34","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210111611","https://openalex.org/I4405259061"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Emma Solomon","raw_affiliation_strings":["Department of Clinical Psychology, Salford Royal Hospital, Salford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Psychology, Salford Royal Hospital, Salford, UK","institution_ids":["https://openalex.org/I2801120809","https://openalex.org/I4210111611"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014436895","display_name":"David M. Taylor","orcid":"https://orcid.org/0000-0002-2557-1710","observed_orcids":["https://orcid.org/0000-0002-2557-1710"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Taylor","raw_affiliation_strings":["Institute of Psychiatry, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Psychiatry, London, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083538986","display_name":"Adrian Hugh Heald","orcid":"https://orcid.org/0000-0002-9537-4050","observed_orcids":["https://orcid.org/0000-0002-9537-4050","https://orcid.org/0009-0009-1515-9747"]},"institutions":[{"id":"https://openalex.org/I2799725268","display_name":"Manchester Academic Health Science Centre","ror":"https://ror.org/04rrkhs81","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799725268"]},{"id":"https://openalex.org/I2801120809","display_name":"Salford Royal NHS Foundation Trust","ror":"https://ror.org/019j78370","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2801120809","https://openalex.org/I4405259061"]},{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]},{"id":"https://openalex.org/I4210111611","display_name":"Salford Royal Hospital","ror":"https://ror.org/027rkpb34","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210111611","https://openalex.org/I4405259061"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Adrian Heald","raw_affiliation_strings":["Department of Diabetes and EndocrinologySalford Royal Hospital\rM6 8HD\rSalford\rUK","The School of Medicine and Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK"],"raw_orcid":"https://orcid.org/0000-0002-9537-4050","affiliations":[{"raw_affiliation_string":"Department of Diabetes and EndocrinologySalford Royal Hospital\rM6 8HD\rSalford\rUK","institution_ids":["https://openalex.org/I2801120809","https://openalex.org/I4210111611"]},{"raw_affiliation_string":"The School of Medicine and Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK","institution_ids":["https://openalex.org/I2799725268","https://openalex.org/I28407311"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019698519","display_name":"Ram Prakash Narayanan","orcid":"https://orcid.org/0000-0003-2840-6507","observed_orcids":["https://orcid.org/0000-0003-2840-6507"]},"institutions":[{"id":"https://openalex.org/I146655781","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96","country_code":"GB","type":"education","lineage":["https://openalex.org/I146655781"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ram Prakash Narayanan","raw_affiliation_strings":["St Helens and Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St Helens and Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, UK","institution_ids":["https://openalex.org/I146655781"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5092252993","display_name":"John Julian Warner-Levy","orcid":"https://orcid.org/0000-0003-2632-7266","observed_orcids":["https://orcid.org/0000-0003-2632-7266"]},"institutions":[{"id":"https://openalex.org/I2799725268","display_name":"Manchester Academic Health Science Centre","ror":"https://ror.org/04rrkhs81","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799725268"]},{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"John Warner-Levy","raw_affiliation_strings":["The School of Medicine and Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The School of Medicine and Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK","institution_ids":["https://openalex.org/I2799725268","https://openalex.org/I28407311"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5083538986"],"corresponding_institution_ids":["https://openalex.org/I2799725268","https://openalex.org/I2801120809","https://openalex.org/I28407311","https://openalex.org/I4210111611"],"apc_list":{"value":2390,"currency":"USD","value_usd":2390},"apc_paid":{"value":2390,"currency":"USD","value_usd":2390},"fwci":1.5686,"has_fulltext":true,"cited_by_count":7,"citation_normalized_percentile":{"value":0.80115104,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":97},"biblio":{"volume":"16","issue":"1","first_page":"169","last_page":"169"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10168","display_name":"COVID-19 and Mental Health","score":0.9214000105857849,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10168","display_name":"COVID-19 and Mental Health","score":0.9214000105857849,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11296","display_name":"COVID-19 and healthcare impacts","score":0.07450000196695328,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12847","display_name":"Healthcare Systems and Challenges","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/3600","display_name":"General Health Professions"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/covid-19","display_name":"COVID-19 pandemic","score":0.9929999709129333},{"id":"https://openalex.org/keywords/prescribing-trends","display_name":"prescribing trends","score":0.5600000023841858},{"id":"https://openalex.org/keywords/psychotropic-drugs","display_name":"psychotropic drugs","score":0.8650000095367432},{"id":"https://openalex.org/keywords/primary-care","display_name":"primary care","score":0.5540000200271606},{"id":"https://openalex.org/keywords/antidepressants","display_name":"antidepressants","score":0.6679999828338623},{"id":"https://openalex.org/keywords/anxiolytics","display_name":"anxiolytics","score":0.8009999990463257},{"id":"https://openalex.org/keywords/hypnotics","display_name":"hypnotics","score":0.996999979019165},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.9800000190734863},{"id":"https://openalex.org/keywords/bronchodilators","display_name":"bronchodilators","score":0.8190000057220459},{"id":"https://openalex.org/keywords/antibiotics","display_name":"antibiotics","score":0.8939999938011169},{"id":"https://openalex.org/keywords/psychiatric-medication","display_name":"psychiatric medication","score":0.5120000243186951},{"id":"https://openalex.org/keywords/access-to-mental-health-care","display_name":"access to mental health care","score":0.7139999866485596},{"id":"https://openalex.org/keywords/england","display_name":"England","score":0.3310000002384186}],"concepts":[{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.8287813663482666},{"id":"https://openalex.org/C89623803","wikidata":"https://www.wikidata.org/wiki/Q12184","display_name":"Pandemic","level":5,"score":0.7586179971694946},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7241164445877075},{"id":"https://openalex.org/C104863432","wikidata":"https://www.wikidata.org/wiki/Q614304","display_name":"Pharmacy","level":2,"score":0.4551751911640167},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.45452064275741577},{"id":"https://openalex.org/C134362201","wikidata":"https://www.wikidata.org/wiki/Q317309","display_name":"Mental health","level":2,"score":0.43216049671173096},{"id":"https://openalex.org/C139265228","wikidata":"https://www.wikidata.org/wiki/Q5283089","display_name":"Distress","level":2,"score":0.4298383593559265},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.4257875680923462},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.4213227927684784},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.4184896647930145},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.3034166693687439},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.2870227098464966},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.17911526560783386},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.1370944380760193},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.106922447681427},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0},{"id":"https://openalex.org/C70410870","wikidata":"https://www.wikidata.org/wiki/Q199906","display_name":"Clinical psychology","level":1,"score":0.0},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.0},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.0}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.1186/s40545-023-00655-9","doi":"https://doi.org/10.1186/s40545-023-00655-9","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s40545-023-00655-9","pdf_url":"https://joppp.biomedcentral.com/counter/pdf/10.1186/s40545-023-00655-9","source":{"id":"https://openalex.org/S2737254583","display_name":"Journal of Pharmaceutical Policy and Practice","issn_l":"2052-3211","issn":["2052-3211"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","norway-1","oarl","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmaceutical Policy and Practice","raw_type":"journal-article"},{"id":"doi:10.21203/rs.3.rs-1939127/v1","doi":"https://doi.org/10.21203/rs.3.rs-1939127/v1","is_oa":true,"landing_page_url":"https://doi.org/10.21203/rs.3.rs-1939127/v1","pdf_url":"https://www.researchsquare.com/article/rs-1939127/latest.pdf","source":{"id":"https://openalex.org/S4306525896","display_name":"Research Square","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Research Square","raw_type":"posted-content"},{"id":"pmh:oai:pubmedcentral.nih.gov:10734137","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10734137","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10734137/pdf/40545_2023_Article_655.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Pharm Policy Pract","raw_type":"Text"},{"id":"pmid:38124123","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38124123","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of pharmaceutical policy and practice","raw_type":"Journal Article"},{"id":"pmh:oai:kclpure.kcl.ac.uk:publications/24bae2ef-7281-4736-89ab-6b7755a8c8df","doi":null,"is_oa":true,"landing_page_url":"https://kclpure.kcl.ac.uk/portal/en/publications/24bae2ef-7281-4736-89ab-6b7755a8c8df","pdf_url":null,"source":{"id":"https://openalex.org/S4306400216","display_name":"Research Portal (King's College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I183935753","host_organization_name":"King's College London","host_organization_lineage":["https://openalex.org/I183935753"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Waheed, U, Stedman, M, Davies, M, Solomon, E, Taylor, D & Heald, A H 2022, 'Changes in Prescribing of Psychotropic Medication in Primary Care through the COVID-19 Pandemic in England : A National Level Prospective Survey', Research square. https://doi.org/10.21203/rs.3.rs-1939127/v1","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1186/s40545-023-00655-9","doi":"https://doi.org/10.1186/s40545-023-00655-9","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s40545-023-00655-9","pdf_url":"https://joppp.biomedcentral.com/counter/pdf/10.1186/s40545-023-00655-9","source":{"id":"https://openalex.org/S2737254583","display_name":"Journal of Pharmaceutical Policy and Practice","issn_l":"2052-3211","issn":["2052-3211"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","norway-1","oarl","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmaceutical Policy and Practice","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4390031850.pdf","grobid_xml":"https://content.openalex.org/works/W4390031850.grobid-xml"},"referenced_works_count":15,"referenced_works":["https://openalex.org/W2038782521","https://openalex.org/W2758317535","https://openalex.org/W3013323152","https://openalex.org/W3017058566","https://openalex.org/W3092893959","https://openalex.org/W3094377467","https://openalex.org/W3103444143","https://openalex.org/W3127601020","https://openalex.org/W3130171947","https://openalex.org/W3194558432","https://openalex.org/W3202623611","https://openalex.org/W3203310594","https://openalex.org/W4210270982","https://openalex.org/W4210604792","https://openalex.org/W4297537469"],"related_works":["https://openalex.org/W4297908039","https://openalex.org/W4294725356","https://openalex.org/W7171560165","https://openalex.org/W7127387115","https://openalex.org/W7171674534","https://openalex.org/W3202623611","https://openalex.org/W4402164336","https://openalex.org/W4408648145","https://openalex.org/W3127403933","https://openalex.org/W3135631895"],"abstract_inverted_index":{"INTRODUCTION:":[0],"The":[1,80,103,223],"COVID-19":[2],"pandemic":[3,110,146,195,217,232],"globally":[4],"impacted":[5,31],"healthcare":[6],"provision.":[7],"Prescribing":[8,38],"changes":[9],"in":[10,143,189,192,203,214,225,243],"common":[11],"medications":[12,120],"can":[13],"be":[14],"used":[15],"as":[16],"a":[17,140,186,240],"marker":[18],"for":[19,40,65,108,130,162,181],"new":[20,66],"diagnoses.":[21],"We":[22],"describe":[23],"how":[24],"the":[25,33,55,109,126,144,193,199,215,246,255],"prescribing":[26,71,138,158,191,211,227,244],"of":[27,43,59,77,151,245],"specific":[28],"psychotropics":[29],"was":[30,239],"by":[32,164,172],"pandemic.":[34],"METHODS:":[35],"Primary":[36],"Care":[37],"data":[39],"different":[41],"classes":[42],"drugs":[44],"from":[45,86,148],"March":[46,87,149],"2017":[47],"to":[48,62,89,96,231,260,266],"February":[49,90],"2022":[50],"were":[51,72,92,115],"considered.":[52],"To":[53],"capture":[54],"impact":[56],"during":[57,125],"periods":[58],"restricted":[60,264],"access":[61,259,265],"health":[63,119,156],"services":[64,261],"diagnoses/existing":[67],"conditions,":[68],"repeat":[69],"prescriptions/episodic":[70],"included":[73],"with":[74,177],"account":[75],"taken":[76],"historical":[78,220],"trends.":[79],"pre-pandemic":[81],"prescriptions":[82,107,124],"issued":[83],"each":[84],"month":[85],"2018":[88],"2020":[91,150],"linearly":[93],"extrapolated":[94],"forward":[95],"give":[97],"an":[98],"expected":[99,106],"annual":[100],"growth":[101],"(EAG).":[102],"monthly":[104,123],"average":[105],"period":[111,218],"(March":[112],"2020-February":[113],"2022)":[114],"compared.":[116],"RESULTS:":[117],"Physical":[118],"had":[121],"lower":[122],"pandemic,":[127],"most":[128],"markedly":[129],"antibiotics":[131],"-":[132,135,167,173],"12.5%":[133],"(EAG":[134,153,166,175,183],"1.3%).":[136],"Bronchodilator":[137],"showed":[139],"marked":[141],"increase":[142,188,224],"early":[145,194],"months":[147],"5%":[152],"0.1%).":[154],"Mental":[155],"medication":[157],"increased":[159],"above":[160,228],"trend":[161,229],"hypnotics/anxiolytics":[163],"0.2%":[165,174],"2.3%),":[168],"while":[169],"antidepressants":[170,201,248],"fell":[171],"5.0%),":[176],"no":[178],"net":[179],"change":[180],"antipsychotics":[182],"2.8%),":[184],"but":[185],"temporary":[187],"antipsychotic":[190],"period.":[196],"For":[197],"all":[198],"main":[200,216,247],"prescribed":[202],"England":[204],"(Sertraline,":[205],"Mirtazapine,":[206],"Venlafaxine,":[207],"Fluoxetine":[208],"and":[209],"Citalopram),":[210],"actually":[212],"decreased":[213],"vs":[219],"trend.":[221],"CONCLUSIONS:":[222],"anxiolytic/hypnotic":[226],"links":[230],"effects":[233],"on":[234],"anxiety/worry.":[235],"If":[236],"anything,":[237],"there":[238],"slight":[241],"fall":[242],"prescribed,":[249],"which":[250],"given":[251],"prevailing":[252],"circumstances":[253],"at":[254],"time,":[256],"suggests":[257],"that":[258],"may":[262],"have":[263],"timely":[267],"assessment.":[268]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":3}],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2023-12-21T00:00:00"}